Pharmacy

Following an audit conducted in February 2011, Gracure has received European Union-Good Manufacturing Practice (EU-GMP) certification for its manufacturing site in Bhiwadi, India, by Belgium's Federal Agency for Medicines & Health Products (FAMHP). The site has been approved for manufacturing of non-sterile dosage forms, which includes capsules (hard shells), liquids, tablets, semi solid and other (dry syrup for reconstitution with water).

The Belgium's FAMHP certificate is accepted by all EU Health Authorities and by authorities of several other countries that recognize EU Certification. A S Bhargava, CMD, Gracure Pharmaceuticals Ltd stated, "This achievement would help Gracure enter European countries with its products and gain confidence and recognition from existing and new clients. "EU GMP is an important milestone in scaling up for new ventures and it was a tremendous team effort of the entire Gracure team which resulted into this success," he added.

The long and rigorous preparation for EU-GMP, which had started in April 2009, finally paid off with receiving the certificate, which further confirmed Gracure and its team’s commitment for quality.